MedCity News

NOVEMBER 1, 2024

The post Heard at HLTH 2024 Part 2: Insights from Innovative Healthcare Executives appeared first on MedCity News. Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.

Healthcare 293

Healthcare Healthcare 293

MedCity News

JANUARY 30, 2024

A preview of ViVE 2024 offers a sneak peek at the agenda and how the Payer and Provider Connect meeting platform initiatives have been revamped to maximize the quantity and quality of meeting for healthcare executives.

Healthcare 300

Healthcare Healthcare 300

MedCity News

JANUARY 2, 2024

A recent Deloitte report found that improving health equity is a top-10 goal for 83% of life sciences and healthcare C-suite executives in 2024. The report also laid out factors that will likely influence health equity in 2024, including AI.

Healthcare 337

Healthcare Healthcare 337

MedCity News

NOVEMBER 25, 2024

Updated schema requirements are easy to mix up — here are a few simple solutions The post Common MRF Mistakes Hospitals Are Making in 2024 appeared first on MedCity News.

282

282

MedCity News

SEPTEMBER 4, 2024

The post How Have Hospitals Fared Financially So Far in 2024? Health systems’ financial results suggest the start of sustained recovery, but persistent challenges remain, including rising expenses and less-than-ideal reimbursement rates from payers. appeared first on MedCity News.

293

293

MedCity News

DECEMBER 10, 2023

Deloitte released a report predicting the key trends that will shape the healthcare landscape in 2024. Some of them include hospital M&A, health systems outsourcing departments and the increasing adoption of generative AI tools.

Healthcare 312

Healthcare Healthcare 312

MedCity News

DECEMBER 3, 2023

The top three areas of concern for employers in 2024 include rising healthcare costs, mental health challenges and cancer care, according to a recent report from Business Group on Health.

Healthcare 317

Healthcare Healthcare 317

MedCity News

FEBRUARY 26, 2024

At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration.

334

334

MedCity News

DECEMBER 29, 2023

There are three key trends for the healthcare industry to follow in 2024, including the rise of AI, increasing cost pressures and M&A activity, according to West Monroe.

Healthcare 322

Healthcare Healthcare 322

MedCity News

DECEMBER 20, 2023

Healthcare’s share of the global PE and VC deal count will likely continue decreasing in 2024, according to a new Pitchbook report. The report also predicted that generative AI and surgical robotics will continue to be hot areas of interest for investors, and that there will be at least three digital health IPOs next year.

Healthcare 317

Healthcare Healthcare 317

MedCity News

SEPTEMBER 8, 2023

per employee on average in 2024, new data from Mercer shows. Employers expect health benefit costs to increase 5.4% This is due to inflationary pressures and health system consolidation.

Healthcare 307

Healthcare Healthcare 307

MedCity News

FEBRUARY 1, 2024

Here are 5 healthcare marketing trends to pay attention to in 2024. To meet evolving consumer expectations, providers must have a strong digital marketing strategy and user experience online.

Retail 300

Retail Marketing Healthcare Healthcare 300

MedCity News

JANUARY 7, 2024

A recent KPMG report laid out several tailwinds and headwinds for payers in 2024. Payers’ tailwinds include reduced recession worries, while their headwinds include Medicare Advantage scrutiny.

284

284

MedCity News

MAY 2, 2024

Where we’ve been, where we’re going, and how healthcare organizations can protect themselves from privacy risks caused by the Meta pixel and other third-party trackers The post The Rising Stakes of Healthcare Data Privacy in 2024: The Need for Practical Guidance appeared first on MedCity News.

Healthcare 297

Healthcare Healthcare 297

MedCity News

NOVEMBER 6, 2023

About half (47%) of nonelderly uninsured veterans will be eligible for Medicaid or subsidies through the ACA Marketplace in 2024, according to a new report from the Urban Institute.

293

293

MedCity News

FEBRUARY 21, 2024

Mari Savickis, Vice President of Public Policy with CHIME, will be moderating a panel discussion as part of the Cybersecurity Pavilion at the ViVE 2024 event in Los Angeles, scheduled for February 25-28. She said her organization anticipates several developments addressing cybersecurity this year.

Healthcare 299

Healthcare Healthcare 299

Fierce Pharma

APRIL 1, 2024

The two most influential proxy advisory firms are rallying investors to vote against the 2024 pay proposal for Soriot at the company’s annual general meeting this month. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again.

278

278

MedCity News

DECEMBER 26, 2023

In looking ahead to 2024, the healthcare industry stands at the cusp of a transformative era of transparency. With impending regulatory changes and growing consumer empowerment, the landscape is poised for continued meaningful progress.

Healthcare 274

Healthcare Healthcare Patients 274

MedCity News

FEBRUARY 12, 2024

The Payer Insights Program at ViVE 2024, in partnership with MedCity News, kicks off day one at the event. This new immersive program will focus on the impact of rising healthcare costs, recent regulatory changes, and innovative payer solutions for optimizing data insights, minimizing costs, and expanding access to care.

Healthcare 284

Healthcare Healthcare 284

MedCity News

NOVEMBER 29, 2023

in 2024, according to a new report from Willis Towers Watson. Globally, health benefit costs are expected to increase 9.9% This is a slightly slower pace than in 2023, which saw a record-high increase of 10.7%.

Healthcare 293

Healthcare Healthcare 293

MedCity News

JANUARY 18, 2024

He predicted that the ability to achieve profitability will be much more important in 2024 than it has been in the past four years or so. This year’s digital health fundraising environment requires startups to focus more on their unit economics and pathway to profitability, according to Ian Wijaya, managing director at Lazard.

Management 293

Management 293

MedCity News

MARCH 6, 2024

Will 2024 bring any change, or will we witness yet another record- and heart-breaking year of preventable deaths?

Biopharma 301

Biopharma 301

MedCity News

DECEMBER 12, 2024

The post ASH 2024 Recap: Movement in Multiple Myeloma, Cell Therapy, Sickle Cell Disease & More appeared first on MedCity News. A multiple myeloma cell therapy has encouraging results analysts say could make it best in its class and a gene-editing therapy is showing early promise in sickle cell disease.

Biopharma 246

Biopharma Pharma 246

MedCity News

DECEMBER 12, 2023

Zocdoc Founder and CEO Oliver Kharraz gave five predictions about how patient preferences will evolve in 2024. Some of them include Americans increasingly seeking cash-pay care options and an uptick in patients seeking mental health appointments before and after the presidential election.

Patients 293

Patients 293

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363

363

Fierce Pharma

DECEMBER 22, 2023

And it is with cautious optimism that industry watchers see the trend continuing in 2024. . | Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.

Biopharma 323

Biopharma 323

MedCity News

JANUARY 8, 2024

Medicare Advantage patients without a primary care physician are perhaps the greatest risk to health plans in 2024. Health plans must adopt best practices to reach and engage MA patients, especially those with multiple, complex conditions. Here are six best practices to consider.

Physicians 284

Physicians Patients 284

MedCity News

SEPTEMBER 26, 2023

The average monthly plan premium for Medicare Advantage is expected to increase only slightly in 2024 from 2023, CMS said. About 73% of beneficiaries will see no increase at all.

284

284

MedCity News

JUNE 5, 2024

More than 100 skilled consultants to self-insured employers shared their perspectives on the changing dynamics in healthcare benefits in MedCity News’ second annual 2024 Benefit Consultant Sentiment Index (The Index): Benefit Consultants’ Perspective on Shifting Employer Healthcare Landscape.

Consulting 274

Consulting Insurance Healthcare Healthcare 274

MedCity News

FEBRUARY 14, 2024

2024 presents an exciting yet challenging landscape for global pharma marketers.

Marketing 283

Marketing Pharma Pharmaceutical Patients 283

MedCity News

MAY 4, 2023

in 2024, about four times higher than it is for the entire U.S. A recent Urban Institute report found that the uninsurance rate for nonelderly people who aren’t citizens will be 39.2% population at 9.8%.

284

284

MedCity News

NOVEMBER 9, 2023

In total, there are 3,959 Medicare Advantage plans being offered for individual enrollment in 2024, a 1% decrease from 2023, according to a new report from KFF.

284

284

MedCity News

AUGUST 11, 2024

The post From Risk to Trust: Tackling Inefficient Provider Verifications in 2024 and Beyond appeared first on MedCity News. The NCQA proposed standards updates are just one part of a healthcare landscape undergoing rapid transformation, but the imperative for optimizing operational processes has never been clearer.

Healthcare 259

Healthcare Healthcare 259

MedCity News

NOVEMBER 1, 2023

MedCity News is inviting startups to apply for the INVEST 2024 Pitch Perfect Startup Contest on May 21-22 at the annual INVEST conference in the Ritz Carlton hotel in Chicago.

Biopharma 283

Biopharma 283

Fierce Pharma

JULY 30, 2024

For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. |

Sales 267

Sales 267

MedCity News

FEBRUARY 16, 2024

Equal parts networking and curated panels covering the latest trends in healthcare investment, MedCity INVEST 2024 is the ideal event to discuss health tech, biopharma, devices and diagnostics investment opportunities. Register today!

Healthcare 273

Healthcare Healthcare Biopharma Networking 273